Are all angiotensin-converting enzyme inhibitors interchangeable?

Journal of the American College of Cardiology

Volumn 37, Issue 5, 2001, Pages 1456-1460

  Furberg, Curt D ^a   Pitt, Bertram ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; MOEXIPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; REVIEW;

EID: 0035312621     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01161-5     Document Type: Article

References (17)

1. Natural statins and stroke risk
2. Class effects. Are drugs within a class interchangeable?
3. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
4. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival And Ventricular Enlargement trial
6. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
7. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on six-week mortality and ventricular function after acute myocardial infarction
8. A randomized factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
9. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
10. Use of "Xapril" in patients with chronic heart failure: A paradigm or epitaph for our times?
11. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure
12. The QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery intervention
13. Effects of ramipril and vitamin E on atherosclerosis: The Study to Evaluate Carotid Ultrasound changes in patients treated with ramipril and vitamin E (SECURE)
14. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
15. Black Americans have an increased rate of angiotensin-converting enzyme inhibitor-associated angioedema
16. A comparison of the cough profile of fosinopril and enalapril in hypertensive patients with a history of ACE inhibitor-associated cough